Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
The study of cytokine storm in COVID-19 has been having different edges in accordance with the knowledge of the disease. Various cytokines have been the focus, especially to define specific treatments; however, there are no conclusive results that fully support any of the options proposed for emerge...
Saved in:
Main Authors: | Yadira Palacios (Author), Leslie Chavez-Galan (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Unusual Presentation of Merkel Cell Carcinoma in the Setting of Immunosuppression on TNF-Alpha Inhibitor Therapy
by: Kristen Delans, et al.
Published: (2022) -
RITUXIMAB EFFICACY IN TREATING SYSTEMIC JUVENILE ARTHRITIS REFRACTORY TO TRADITIONAL IMMUNOSUPPRESSANT AND TNF BLOCKER THERAPY
by: E.I. Alexeeva, et al.
Published: (2007) -
RITUXIMAB EFFICACY IN TREATING SYSTEMIC JUVENILE ARTHRITIS REFRACTORY TO TRADITIONAL IMMUNOSUPPRESSANT AND TNF BLOCKER THERAPY
by: E.I. Alexeeva, et al.
Published: (2007) -
Is immunosuppressive therapy an effective treatment for COVID-19? - literature review
by: Barbara Ostrowska, et al.
Published: (2023) -
COVID-19 in Immunosuppressed Children
by: Emanuele Nicastro, et al.
Published: (2021)